Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet regimen for managing HIV infection. This drug combines three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the HIV's ability to replicate within the body, significantly lowering the viral quantity